Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

2021306 citationsJournal Articlebronze Open Access

Authors

Aaron Orkin · University of Toronto

Peter Gill · University of Toronto

Davina Ghersi · National Health and Medical Research Council

Lisa Campbell

Jeremy Sugarman · Johns Hopkins University

Richard Emsley · King's College London

Philippe Gabríel Steg · Université Paris Cité

Abstract

CONSERVE offers an extension to CONSORT and SPIRIT that could improve the transparency, quality, and completeness of reporting important modifications to trials in extenuating circumstances such as COVID-19.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life COVID-19 and healthcare impacts Healthcare cost, quality, practices

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 326, Issue 3, pp. 257-257

DOI: 10.1001/jama.2021.9941

Field-Weighted Citation Impact: 75.48